A. Ibdaih

PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas

F. Ducray, D. Figarella-Branger, R. Appay, 2019, Neuro-Oncology.

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

M. J. van den Bent, M. Taphoorn, A. Brandes, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

R. Mirimanoff, M. J. van den Bent, A. Brandes, 2009, Neuro-oncology.